NEWS

SEPTEMBER 11, 2018

TELA Bio® Announces Publication of Case Series Evaluating OviTex® Reinforced BioScaffolds in Hiatal and Inguinal Hernia Repair

READ MORE

JUNE 7, 2018

TELA Bio® Announces Initial Data from BRAVO Study of OviTex® Reinforced BioScaffolds for Ventral Hernia Repair

READ MORE

MAY 31, 2018

TELA Bio® Announces Plans to Launch OviTex® Reinforced BioScaffolds in Europe

READ MORE

APR 16, 2018

TELA Bio Announces Series B Investment by Checkmate Capital

READ MORE

MAR 26, 2018

TELA Bio Announces Investment Agreement with ProMedica Innovations Venture Fund

READ MORE

MAR 12, 2018

TELA Bio Announces Results from Retrospective Study of OviTex® Reinforced BioScaffolds for Abdominal Wall Reconstruction

READ MORE

OCT 30, 2017

TELA Bio Announces Hiring of Greg Firestone as Vice President of Strategic Customer Relations

READ MORE

OCT 25, 2017

Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement

READ MORE

JUN 5, 2017

TELA Bio to Present Surgeon Feedback from Initial Clinical Experience with OviTex™ Reinforced BioScaffolds and Product Permeability Data at Abdominal Wall Reconstruction Conference

READ MORE

APR 25, 2017

TELA Bio Initiates BRAVO Study of OviTex™ Reinforced BioScaffolds for Hernia Repair

READ MORE

MAR 31, 2017

TELA Bio to Participate in 16th Annual Needham Healthcare Conference

READ MORE

NOV 21, 2016

TELA Bio Announces Settlement of Litigation with LifeCell

READ MORE

NOV 1, 2016

TELA Bio Announces OviTex™ Reinforced BioScaffolds Implanted in 100 Hernia Repair Procedures

READ MORE

JUL 13, 2016

TELA Bio Announces Commercial Launch of OviTex™ Reinforced BioScaffolds for Ventral Hernia Repair and Abdominal Wall Reconstruction

READ MORE

JUN 15, 2016

Results From Studies of OviTex™ Reinforced BioScaffolds Presented at Abdominal Wall Reconstruction Conference

READ MORE